• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像引导下前列腺癌的主动监测:是时候告别基于方案的活检了。

Magnetic Resonance Imaging-guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies.

作者信息

Giganti Francesco, Stavrinides Vasilis, Moore Caroline M

机构信息

Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.

Division of Surgery & Interventional Science, University College London, London, UK.

出版信息

Eur Urol Open Sci. 2022 Feb 26;38:40-43. doi: 10.1016/j.euros.2021.08.016. eCollection 2022 Apr.

DOI:10.1016/j.euros.2021.08.016
PMID:35243397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885616/
Abstract

UNLABELLED

Traditional protocols for active surveillance (AS) are commonly based on digital rectal examination, prostate-specific antigen (PSA), and standard transrectal biopsy, meaning that initial classification errors and inaccurate lesion monitoring can occur. Protocol-based biopsies are performed to assess changes in cancer grade and extent at prespecified intervals, but this approach represents a barrier to AS adherence and tolerability. There is evidence to support the use of magnetic resonance imaging (MRI) during AS, as this technique (associated with favourable PSA kinetics) offers an opportunity to follow patients on AS without the need for routine, protocol-based biopsies in the absence of signs of radiological progression provided that image quality, interpretation, and reporting of serial imaging are of the highest standards.

PATIENT SUMMARY

In this report we looked at the role of magnetic resonance imaging (MRI) scans in avoiding unnecessary prostate biopsies for patients being monitored for low- or intermediate-risk prostate cancer. We conclude that patients on active surveillance can be monitored with MRI scans over time and that biopsies could be used only when there are changes on MRI or a rising prostate-specific antigen (PSA) not explained by an increase in prostate size.

摘要

未标注

传统的主动监测(AS)方案通常基于直肠指检、前列腺特异性抗原(PSA)和标准经直肠活检,这意味着可能会出现初始分类错误和病变监测不准确的情况。基于方案的活检是为了在预定间隔评估癌症分级和范围的变化,但这种方法对AS的依从性和耐受性构成了障碍。有证据支持在AS期间使用磁共振成像(MRI),因为这种技术(与良好的PSA动力学相关)提供了一个机会,在没有放射学进展迹象的情况下,无需进行常规的、基于方案的活检,就可以对接受AS的患者进行随访,前提是连续成像的图像质量、解读和报告达到最高标准。

患者总结

在本报告中,我们探讨了磁共振成像(MRI)扫描在避免对低风险或中风险前列腺癌患者进行不必要的前列腺活检方面的作用。我们得出结论,接受主动监测的患者可以通过MRI扫描进行长期监测,只有在MRI出现变化或前列腺特异性抗原(PSA)升高且无法用前列腺大小增加来解释时才进行活检。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0a/8885616/a83864758d75/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0a/8885616/aabe6de58e6f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0a/8885616/a83864758d75/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0a/8885616/aabe6de58e6f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0a/8885616/a83864758d75/gr2.jpg

相似文献

1
Magnetic Resonance Imaging-guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies.磁共振成像引导下前列腺癌的主动监测:是时候告别基于方案的活检了。
Eur Urol Open Sci. 2022 Feb 26;38:40-43. doi: 10.1016/j.euros.2021.08.016. eCollection 2022 Apr.
2
Four-year outcomes from a multiparametric magnetic resonance imaging (MRI)-based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies.基于多参数磁共振成像(MRI)的主动监测计划的 4 年结果:PSA 动力学和连续 MRI 扫描可避免进行协议活检。
BJU Int. 2019 Mar;123(3):429-438. doi: 10.1111/bju.14513. Epub 2018 Oct 9.
3
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.使用前列腺癌影像学改变连续评估标准和 MRI/经直肠超声融合技术以及经会阴饱和活检,对主动监测患者进行选择的标准化磁共振成像报告。
Eur Urol Focus. 2021 Jan;7(1):102-110. doi: 10.1016/j.euf.2019.03.001. Epub 2019 Mar 13.
4
Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.符合前列腺癌研究国际主动监测(PRIAS)方案的比例和不遵守方案者的疾病再分类。
Eur Urol. 2015 Nov;68(5):814-21. doi: 10.1016/j.eururo.2015.06.012. Epub 2015 Jun 29.
5
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.对临床局限性前列腺癌主动监测的系统评价,以制定关于纳入中危疾病、纳入时的活检特征及监测以及监测重复活检策略的建议。
Eur Urol. 2022 Apr;81(4):337-346. doi: 10.1016/j.eururo.2021.12.007. Epub 2021 Dec 31.
6
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study.磁共振成像引导下对1或2级前列腺癌患者进行主动监测且无需每年重复活检:前瞻性PROMM-AS研究
Eur Urol Open Sci. 2023 Dec 19;59:30-38. doi: 10.1016/j.euros.2023.10.005. eCollection 2024 Jan.
7
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.在随访 1 年后,对接受主动监测的低危前列腺癌男性进行连续多参数磁共振成像和磁共振成像引导下活检的价值。
Eur Urol Focus. 2019 May;5(3):407-415. doi: 10.1016/j.euf.2017.12.008. Epub 2018 Jan 10.
8
Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.采用主动监测方案对低危前列腺癌患者进行基于影像引导的基线穿刺活检和多参数磁共振成像监测的进展和治疗率。
BJU Int. 2018 Jul;122(1):59-65. doi: 10.1111/bju.14166. Epub 2018 Mar 8.
9
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.基于磁共振成像和前列腺特异性抗原密度的风险分层,可能会减少接受低风险前列腺癌主动监测的男性不必要的后续活检程序。
BJU Int. 2017 Oct;120(4):511-519. doi: 10.1111/bju.13836. Epub 2017 Apr 4.
10
Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.磁共振成像引导下的前列腺癌主动监测确认性活检。
JAMA Netw Open. 2019 Sep 4;2(9):e1911019. doi: 10.1001/jamanetworkopen.2019.11019.

引用本文的文献

1
Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review.对 Gleason 7(3+4)前列腺癌采用主动监测:一项叙述性综述。
Can Urol Assoc J. 2024 Apr;18(4):135-144. doi: 10.5489/cuaj.8539.
2
Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings.在接受主动监测的前列腺癌患者中,连续双参数MRI上的Delta影像组学模式与病理升级相关:初步研究结果。
Front Oncol. 2023 Sep 5;13:1166047. doi: 10.3389/fonc.2023.1166047. eCollection 2023.
3
Magnetic Resonance Imaging-based Monitoring in Active Surveillance: Are We Ready To Jump on the Bandwagon?

本文引用的文献

1
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis.基于前列腺 MRI 影像学表现预测前列腺癌主动监测中进展的可靠性:系统评价和荟萃分析。
Eur Urol. 2021 Nov;80(5):549-563. doi: 10.1016/j.eururo.2021.05.001. Epub 2021 May 19.
2
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study.MRI 引导下靶向活检对主动监测患者停药率的影响:PRIAS 研究中 MRI 的应用反思。
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1048-1054. doi: 10.1038/s41391-021-00343-2. Epub 2021 Apr 8.
3
基于磁共振成像的主动监测:我们准备好跟风了吗?
Eur Urol Open Sci. 2022 Feb 26;38:49-51. doi: 10.1016/j.euros.2022.02.001. eCollection 2022 Apr.
The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance.
前列腺磁共振成像和主动监测中精准性的重要性。
Eur Urol. 2021 Apr;79(4):560-563. doi: 10.1016/j.eururo.2021.01.016. Epub 2021 Feb 3.
4
Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.在前列腺癌主动监测的男性中,连续前列腺多参数磁共振成像的诊断准确性和预后价值。
Eur Urol Oncol. 2022 Oct;5(5):537-543. doi: 10.1016/j.euo.2020.11.007. Epub 2021 Jan 19.
5
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.基于磁共振成像的前列腺癌主动监测的 5 年结果:一项大型队列研究。
Eur Urol. 2020 Sep;78(3):443-451. doi: 10.1016/j.eururo.2020.03.035. Epub 2020 Apr 30.
6
The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.主动监测中的磁共振成像(MRIAS)试验:使用基线多参数磁共振成像和饱和活检来降低监测前列腺活检的频率。
J Urol. 2020 May;203(5):910-917. doi: 10.1097/JU.0000000000000693. Epub 2019 Dec 11.
7
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.主动监测(ASIST)中男性系统活检与磁共振成像及靶向和系统活检的随机研究:活检后 2 年随访。
Eur Urol. 2020 Mar;77(3):311-317. doi: 10.1016/j.eururo.2019.10.007. Epub 2019 Nov 8.
8
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南小组对局部前列腺癌延迟有治愈意图治疗的共识声明:一项国际合作研究(DETECTIVE 研究)。
Eur Urol. 2019 Dec;76(6):790-813. doi: 10.1016/j.eururo.2019.09.020. Epub 2019 Oct 3.
9
Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.磁共振成像引导下的前列腺癌主动监测确认性活检。
JAMA Netw Open. 2019 Sep 4;2(9):e1911019. doi: 10.1001/jamanetworkopen.2019.11019.
10
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.主动监测磁共振成像研究(ASIST):一项随机多中心前瞻性试验的结果。
Eur Urol. 2019 Feb;75(2):300-309. doi: 10.1016/j.eururo.2018.06.025. Epub 2018 Jul 13.